scholarly journals Alterações neuroanatômicas do encéfalo na malformação Arnold-Chiari II

2019 ◽  
pp. e710
Author(s):  
Marcelo José da Silva de Magalhães ◽  
Brunno Pedreira Montenegro Pimenta ◽  
Heitor Oliveira Gomes ◽  
José Valci Fernandes Neto ◽  
Rônney Vasconcelos de Oliveira ◽  
...  

Objetivo: Descrever as alterações neuroanatômicas do SNC encontradas nos exames de neuroimagem nos pacientes com malformação de Chiari II. Métodos: Trata-se de uma revisão descritiva baseada em artigos provenientes da base de dados BVS, Scielo e PubMed. Foram utilizados artigos compreendidos em um período de 21 anos (entre 1997 e 2016). Os descritores utilizados foram “Chiari II”, “fetal surgery”, “hydrocephalus”, “intrauterine surgery”, “myelomeningocele”, “prenatal”, “symptomatic Chiari II”, “spina bifida” e “spinal dysraphisms”. Resultados: As malformações de Chiari II encontram-se inseridas no espectro de anormalidades congênitas do sistema nervoso central (SNC). É caracterizada por uma deformidade complexa da fossa posterior associada quase sempre a uma malformação da coluna vertebral. As alterações encefálicas mais sugestivas dessa patologia são anormalidades cerebelares; deslocamento caudal da ponte, IV ventrículo e bulbo; torção medular; IV ventrículo em formato anormal e hipoplasia da tenda do cerebelo e do teto do mesencéfalo. O diagnóstico pode ser realizado através da ultrassonografia, tomografia computadorizada e ressonância magnética. Considerações finais: A Malformação de Chiari II é uma doença que apresenta quadro clínico e alterações radiológicas complexas e extensas. Mais estudos que considerem as alterações morfológicas são necessários.

2021 ◽  
Author(s):  
Neeltje Crombag ◽  
Adalina Sacco ◽  
Bernadette Stocks ◽  
Philippe De Vloo ◽  
Johannes Van Der Merwe ◽  
...  

2015 ◽  
Vol 50 (6) ◽  
pp. 1037-1041 ◽  
Author(s):  
Beatrice Dionigi ◽  
Joseph A. Brazzo ◽  
Azra Ahmed ◽  
Christina Feng ◽  
Yaotang Wu ◽  
...  

2021 ◽  
Vol 58 (S1) ◽  
pp. 306-306
Author(s):  
L. Lara‐Ávila ◽  
M. Martinez‐Rodriguez ◽  
R. Villalobos‐Gómez ◽  
H. López‐Briones ◽  
R. Cruz‐Martinez

2018 ◽  
Vol 45 (6) ◽  
pp. 430-434 ◽  
Author(s):  
Luca Mazzone ◽  
Ueli Moehrlen ◽  
Barbara Casanova ◽  
Samira Ryf ◽  
Nicole Ochsenbein-Kölble ◽  
...  

Author(s):  
Luc Joyeux ◽  
Enrico Danzer ◽  
Alan W Flake ◽  
Jan Deprest

Spina bifida aperta (SBA) is one of the most common congenital malformations. It can cause severe lifelong physical and neurodevelopmental disabilities. Experimental and clinical studies have shown that the neurological deficits associated with SBA are not simply caused by incomplete neurulation at the level of the lesion. Additional damage is caused by prolonged exposure of the spinal cord and nerves to the intrauterine environment and a suction gradient due to cerebrospinal fluid leakage, leading to progressive downward displacement of the hindbrain. This natural history can be reversed by prenatal repair. A randomised controlled trial demonstrated that mid-gestational maternal-fetal surgery for SBA decreases the need for ventriculoperitoneal shunting and hindbrain herniation at 12 months and improves neurological motor function at 30 months of age. This came at the price of maternal and fetal risks, the most relevant ones being increased prematurity and a persistent uterine corporeal scar. Recently minimally invasive fetal approaches have been introduced clinically yet they lack extensive experimental or clinical trials. We aim to provide clinicians with the essential information necessary to counsel SBA parents as the basis for considering referral of selected patients to expert fetal surgery centres. We review the reported clinical outcomes and discuss recent developments of potentially less invasive fetal SBA approaches.


2019 ◽  
Vol 24 (5) ◽  
pp. 539-548 ◽  
Author(s):  
Elizabeth N. Alford ◽  
Betsy D. Hopson ◽  
Frederick Safyanov ◽  
Anastasia Arynchyna ◽  
Robert J. Bollo ◽  
...  

OBJECTIVENeurosurgical management preferences related to myelomeningocele (MMC) care demonstrate significant variability. The authors sought to evaluate variability in practice patterns across a group of senior pediatric neurosurgeons. The purpose of this study was to identify the extent of variability and of consensus with regard to neurosurgical management of MMC and associated hydrocephalus, Chiari II malformation, and tethered spinal cord.METHODSA 43-question survey was distributed electronically to the members of the American Society of Pediatric Neurosurgeons (ASPN). The survey covered domains such as clinic case volume, newborn management, hydrocephalus management, transition to adulthood, clinical indications for shunt revision, Chiari II malformation decompression (C2MD), and tethered cord release (TCR). Ninety responses were received from 200 active ASPN members, for an overall response rate of 45%.RESULTSThe majority (58%) of respondents closed 5–15 new cases of open MMC per year. Nearly all (98%) respondents perform back closure within 48 hours of birth, with the majority imbricating the placode and striving for a 3- to 4-layer closure. The most consistent indications for surgical intervention in early hydrocephalus were CSF leak from the back (92%), progressive ventricular enlargement (89%), and brainstem symptoms, including apnea/bradycardia (81%), stridor (81%), and dysphagia (81%). Eighty percent of respondents indicated that spina bifida care is delivered through multidisciplinary clinics, with neurosurgery, orthopedic surgery, urology, physical therapy, and social work as the most common disciplines included. One-third of clinics see both pediatric and adult patients, one-third offer a formal transition program to adult care, and one-third have no transition program. The vast majority of respondents offer prenatal counseling (95%), referral for in utero closure (66%), and endoscopic third ventriculostomy/choroid plexus cauterization (72%). Respondents were more willing to perform shunt revision for symptoms alone than for image changes alone. An asymptomatic broken shunt without ventricular enlargement produced responses evenly divided between observation, intervention, and further investigation. Operative shunt exploration was always performed before C2MD by 56% of respondents and performed sometimes by 40% of respondents. Symptoms of brainstem dysfunction were the strongest clinical triggers reported for C2MD, while declines in urinary continence, leg strength or sensation, or ambulation were the most consistent thresholds for TCR.CONCLUSIONSSignificant disparities exist surrounding key areas of decision making regarding treatment for patients with MMC, though there are central areas of agreement among ASPN members. Additionally, there is significant variation in the clinical management of chronic hydrocephalus, C2MD, and TCR, underscoring the need for further research into these specific areas.


The Lancet ◽  
1999 ◽  
Vol 353 (9150) ◽  
pp. 406 ◽  
Author(s):  
Gary Magram
Keyword(s):  

2017 ◽  
Vol 50 ◽  
pp. 357-357
Author(s):  
S. Sarmento ◽  
H.J. Milani ◽  
M.M. Barbosa ◽  
S. Cavalheiro ◽  
I. Suriano ◽  
...  

2020 ◽  
Vol 29 (3) ◽  
pp. 480-493
Author(s):  
VIRGINIA L. BARTLETT ◽  
MARK J. BLITON

Open-uterine surgery to repair spina bifida, or ‘fetal surgery of open neural tube defects,’ has generated questions throughout its history—and continues to do so in a variety of contexts. As clinical ethics consultants who worked (Mark J. Bliton) and trained (Virginia L. Bartlett) at Vanderbilt University—where the first successful cases of open-uterine repair of spina bifida were carried out—we lived with these questions for nearly two decades. We worked with clinicians as they were developing and offering the procedure, with researchers in refining and studying the procedure, and with pregnant women and their partners as they considered whether to undergo the procedure. From this experience in the early studies at Vanderbilt, we learned that pregnant women and their partners approach the clinical uncertainty of such a risky procedure with a curious and unique combination of practicality, self-reflection, fear, and overwhelming hope. These early experiences were a major contributing factor to the inclusion of an ethics-focused interview in the informed consent process for the Management of Myelomeningocele Study (MOMS) trial study design.


Sign in / Sign up

Export Citation Format

Share Document